Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2019 Jan-Mar;33(1):47–53. doi: 10.1097/WAD.0000000000000288

Table 4.

Clinical characteristics per PPA variant

PPA variant
Clinical characteristics Whole Group (=33) PPA-G (n=14) PPA-S (n=6) PPA-L (n=13)
Age at onset, mean (SD) 68.55 (7.49) 68.86 (7.74) 66.17 (5.27) 69.31 (7.85)
Symptom onset time, median (IQR) 2 (1) 2 (1) 2.5 (1.75) 3 (1.25)
Apraxia of Speech (AoS), n (%) 7 (21%) 7 (50%) 0 (0%) 0 (0%)
First symptom
 Word finding, n (%) 22 (67%) 8 (57%) 2 (33%) 12 (92%)
 Comprehension, n (%) 2 (6%) 0 (0%) 1 (17%) 1 (8%)
 Naming, n (%) 5 (15%) 2 (14%) 3 (50%) 0 (0%))
 Effortful speech/Articulation, n (%) 4 (12%) 4 (29% 0 (0%) 0 (0%)
Structural imaging (brain MR/CT)
 Normal, n (%) 11 (33%) 3 (21%) 1 (17%) 7 (53%)
 Atrophy, n (%) 17 (51%) 10 (71%) 3 (50%) 4 (31%)
 Not available, n (%) 5 (15%) 1 (7%) 2 (33%) 2 (23%)
Functional imaging (brain PET/SPECT)
 Normal, n (%) 8 (24%) 2 (15%) 2 (33%) 4 (31%)
 Abnormal, n (%) 12 (36% 5 (35%) 0 (0%) 7 (54%)
 Not available, n (%) 13 (40%) 7 (50%) 4 (67%) 2 (15%)

Notes. PPA-G = Primary progressive aphasia – Agrammatic/Nonfluent variant, PPA-S = Primary progressive aphasia – semantic variant, PPA-L = Primary progressive aphasia – logopenic variant, SD= standard deviation, MR = magnetic resonance, CT= computerized tomography, PET= Positron emission tomography, SPECT= Single-photon emission computed tomography